Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION, USP
| Report ID | 201627 |
| Drug Identification Number | 02491680 |
| Brand name | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 5 mL |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-10-01 |
| Actual start date | |
| Estimated end date | 2024-06-24 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-05 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to production delays, fresh dated stock of our HYDROmorphone Hydrochloride Injection, USP 10 mg/mL SD Vial 5 mL will not be available until June 24, 2024 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2024-04-05 | French | Compare |
| v8 | 2024-04-05 | English | Compare |
| v7 | 2024-01-09 | French | Compare |
| v6 | 2024-01-09 | English | Compare |
| v5 | 2023-11-01 | French | Compare |
| v4 | 2023-11-01 | English | Compare |
| v3 | 2023-10-02 | English | Compare |
| v2 | 2023-08-11 | French | Compare |
| v1 | 2023-08-11 | English | Compare |
Showing 1 to 9 of 9